Clinical and genetic evaluations of Zimmermann-Laband syndrome with gingival fibromatosis: a rare case report

Zimmermann-Laband Syndrome (ZLS; MIM 135500) is a rare genetic disorder with the main clinical manifestations of gingival fibromatosis and finger/toe nail hypoplasia. KCNH1 (potassium channel, voltage-gated, subfamily H, member-1), KCNN3 (potassium channel, voltage-gated, subfamily H, member-3) and ATP6V1B2 (ATPase H+ transporting V1 subunit B2) genes are considered causative genes for ZLS. However, there are limited reports about the diverse clinical presentation and genetic heterogeneity. Reporting more information on phenotype-genotype correlation and the treatment of ZLS is necessary. This case reported a 2-year-old patient with gingival enlargement that failure of eruption of the deciduous teeth and severe hypoplasia of nails. Based on a systemic examination and a review of the relevant literature, we made an initial clinical diagnosis of ZLS. A novel pathogenic variant in the KCNH1 gene was identified using whole-exome sequencing to substantiate our preliminary diagnosis. The histopathological results were consistent with gingival fibromatosis. Gingivectomy and gingivoplasty were performed under general anesthesia. After surgery, the gingival appearance improved significantly, and the masticatory function of the teeth was restored. After 2-year follow-up, the gingival showed slightly hyperplasia. Systemic examination and gene sequencing firstly contribute to provide information for an early diagnosis for ZLS, then timely removal of the hyperplastic gingival facilitates the establishment of a normal occlusal relationship and improves oral aesthetics.

Zimmermann-Laband syndrome; Gingival fibromatosis; Gingivectomy; Case report

[1] Fukai R, Saitsu H, Tsurusaki Y, Sakai Y, Haginoya K, Takahashi K, et al. De novo KCNH1 mutations in four patients with syndromic developmental delay, hypotonia and seizures. Journal of Human Genetics. 2016; 61: 381–387.

[2] Castori M, Valiante M, Pascolini G, Leuzzi V, Pizzuti A, Grammatico P. Clinical and genetic study of two patients with Zimmermann-Laband syndrome and literature review. European Journal of Medical Genetics. 2013; 56: 570–576.

[3] Kortüm F, Caputo V, Bauer CK, Stella L, Ciolfi A, Alawi M, et al. Mutations in KCNH1 and ATP6V1B2 cause Zimmermann-Laband syndrome. Nature Genetics. 2015; 47: 661–667.

[4] Schwarz M, Ryba L, Křepelová A, Moslerová V, Zelinová M, Turnovec M, et al. Zimmermann-Laband syndrome in monozygotic twins with a mild neurobehavioral phenotype lacking gingival overgrowth—a case report of a novel KCNN3 gene variant. American Journal of Medical Genetics. 2022; 188: 1083–1087.

[5] Bauer CK, Schneeberger PE, Kortüm F, Altmüller J, Santos-Simarro F, Baker L, et al. Gain-of-function mutations in KCNN3 encoding the small-conductance Ca2+-activated K+ channel SK3 cause Zimmermann-Laband syndrome. American Journal of Human Genetics. 2019; 104: 1139–1157.

[6] Gripp KW, Smithson SF, Scurr IJ, Baptista J, Majumdar A, Pierre G, et al. Syndromic disorders caused by gain-of-function variants in KCNH1, KCNK4, and KCNN3—a subgroup of K+ channelopathies. European Journal of Human Genetics. 2021; 29: 1384–1395.

[7] Buggenhout GJV, Brunner HG, Trommelen JC, Hamel BC. Zimmermann-Laband syndrome in a patient with severe mental retardation. Genetic Counseling. 1995; 6: 321–327.

[8] Doufexi A, Mina M, Ioannidou E. Gingival overgrowth in children: epidemiology, pathogenesis, and complications. A literature review. Journal of Periodontology. 2005; 76: 3–10.

[9] Boutiou E, Ziogas IA, Giannis D, Doufexi A. Hereditary gingival fibromatosis in children: a systematic review of the literature. Clinical Oral Investigations. 2021; 25: 3599–3607.

[10] Almiñana-Pastor PJ, Buitrago-Vera PJ, Alpiste-Illueca FM, Catalá-Pizarro M. Hereditary gingival fibromatosis: characteristics and treatment approach. Journal of Clinical and Experimental Dentistry. 2017; 9: e599–e602.

[11] Lin PH, Hong HH. Gingival fibromatosis associated with Zimmermann-Laband syndrome: a case report. Journal of The Taiwan Academy of Periodontology. 2014; 19: 238–247.

[12] Lin Z, Wang T, Sun G, Huang X. Report of a case of Zimmermann-Laband syndrome with new manifestations. International Journal of Oral and Maxillofacial Surgery. 2010; 39: 937–941.

[13] Laband PF, Habib G, Humphreys GS. Hereditary gingival fibromatosis: report of an affected family with associated splenomegaly and skeletal and soft-tissue abnormalities. Oral Surgery, Oral Medicine, Oral Pathology. 1964; 17: 339–351.

[14] Bakaeen G, Scully C. Hereditary gingival fibromatosis in a family with the Zimmermann-Laband syndrome. Journal of Oral Pathology and Medicine. 1991; 20: 457–459.

[15] Yuan Y, Zhang J, Chang Q, Zeng J, Xin F, Wang J, et al. De novo mutation in ATP6V1B2 impairs lysosome acidification and causes dominant deafness-onychodystrophy syndrome. Cell Research. 2014; 24: 1370–1373.

[16] Campeau PM, Kasperaviciute D, Lu JT, Burrage LC, Kim C, Hori M, et al. The genetic basis of DOORS syndrome: an exome-sequencing study. The Lancet Neurology. 2014; 13: 44–58.

[17] Gao X, Dai P, Yuan Y. Genetic architecture and phenotypic landscape of deafness and onychodystrophy syndromes. Human Genetics. 2022; 141: 821–838.

[18] Simons C, Rash LD, Crawford J, Ma L, Cristofori-Armstrong B, Miller D, et al. Mutations in the voltage-gated potassium channel gene KCNH1 cause Temple-Baraitser syndrome and epilepsy. Nature Genetics. 2015; 47: 73–77.

[19] Van Buggenhout GJ, Brunner HG, Trommelen JC, Hamel BC. Zimmermann-Laband syndrome in a patient with severe mental retardation. Genetic Counseling. 1995; 6: 321–327.

[20] Inuzuka LM, Macedo-Souza LI, Della-Rippa B, Monteiro FP, Delgado DDS, Godoy LF, et al. ATP6V1B2-related epileptic encephalopathy. Epileptic Disorders. 2020; 22: 317–322.

[21] Shah N, Gupta YK, Ghose S. Zimmermann-Laband syndrome with bilateral developmental cataract—a new association? International Journal of Paediatric Dentistry. 2004; 14: 78–85.

[22] de Pina Neto JM, Soares LR, Souza AH, Petean EB, Velludo MA, de Freitas AC, et al. A new case of Zimmermann-Laband syndrome with mild mental retardation, asymmetry of limbs, and hypertrichosis. American Journal of Medical Genetics. 1988; 31: 691–695.

[23] Douzgou S, Mingarelli R, Dallapiccola B. Gingival overgrowth, congenital generalized hypertrichosis, mental retardation and epilepsy: case report and overview. Clinical Dysmorphology. 2009; 18: 205–208.

[24] Chodirker BN, Chudley AE, Toffler MA, Reed MH, Opitz JM, Reynolds JF. Zimmerman-Laband syndrome and profound mental retardation. American Journal of Medical Genetics. 1986; 25: 543–547.

[25] Dumić M, Crawford C, Ivković I, Cvitanović M, Batinica S. Zimmerman-Laband syndrome: an unusually early presentation in a newborn girl. Croatian Medical Journal. 1999; 40: 102–103.

[26] Atabek ME, Pirgon O, Sert A, Toy H. Zimmermann-Laband syndrome in an infant with an atypical histologic finding. Pediatric and Developmental Pathology. 2005; 8: 654–657.

[27] Holzhausen M, Gonçalves D, Corrêa FDOB, Spolidorio LC, Rodrigues VC, Orrico SRP. A case of Zimmermann-Laband syndrome with supernumerary teeth. Journal of Periodontology. 2003; 74: 1225–1230.

[28] Bauer CK, Schwarz JR. Physiology of EAG K+ channels. The Journal of Membrane Biology. 2001; 182: 1–15.

[29] Ludwig J, Terlau H, Wunder F, Brüggemann A, Pardo LA, Marquardt A, et al. Functional expression of a rat homologue of the voltage gated either a go-go potassium channel reveals differences in selectivity and activation kinetics between the Drosophila channel and its mammalian counterpart. The EMBO Journal. 1994; 13: 4451–4458.

[30] Hemmerlein B, Weseloh RM, Mello de Queiroz F, Knötgen H, Sánchez A, Rubio ME, et al. Overexpression of Eag1 potassium channels in clinical tumours. Molecular Cancer. 2006; 5: 41.

[31] Pardo LA, Stühmer W. The roles of K+ channels in cancer. Nature Reviews Cancer. 2014; 14: 39–48.

[32] Sanchez A, Urrego D, Pardo LA. Cyclic expression of the voltage-gated potassium channel K(V)10.1 promotes disassembly of the primary cilium. EMBO Reports. 2016; 17: 708–723.

[33] Urrego D, Sánchez A, Tomczak AP, Pardo LA. The electric fence to cell-cycle progression: do local changes in membrane potential facilitate disassembly of the primary cilium?: Timely and localized expression of a potassium channel may set the conditions that allow retraction of the primary cilium. BioEssays. 2017; 39: 1600190.

[34] Ganetzky B, Robertson GA, Wilson GF, Trudeau MC, Titus SA. The eag family of K+ channels in Drosophila and mammals. Annals of the New York Academy of Sciences. 1999; 868: 356–369.

[35] Hoischen A, van Bon BWM, Gilissen C, Arts P, van Lier B, Steehouwer M, et al. De novo mutations of SETBP1 cause Schinzel-Giedion syndrome. Nature Genetics. 2010; 42: 483–485.

[36] Xiang JJ, Ding Y, Yang F, Gao A, Zhang W, Tang H, et al. Genetic analysis of children with unexplained developmental delay and/or intellectual disability by whole-exome sequencing. Frontiers in Genetics. 2021; 12: 738561.

[37] Kim H, Higgins AW, Herrick SR, Kishikawa S, Nicholson L, Kutsche K, et al. Candidate loci for Zimmermann-Laband syndrome at 3p14.3. American Journal of Medical Genetics. 2007; 143A: 107–111.

[38] Morgan A, Braden R, Wong MMK, Colin E, Amor D, Liégeois F, et al. Speech and language deficits are central to SETBP1 haploinsufficiency disorder. European Journal of Human Genetics. 2021; 29: 1216–1225.

[39] Dongari-Bagtzoglou A; Research, Science and Therapy Committee, American Academy of Periodontology. Drug-associated gingival enlargement. Journal of Periodontology. 2004; 75: 1424–1431.

[40] Gawron K, Łazarz-Bartyzel K, Potempa J, Chomyszyn-Gajewska M. Gingival fibromatosis: clinical, molecular and therapeutic issues. Orphanet Journal of Rare Diseases. 2016; 11: 9.

[41] Coletta RD, Graner E. Hereditary gingival fibromatosis: a systematic review. Journal of Periodontology. 2006; 77: 753–764.

[42] Gawron K, Łazarz-Bartyzel K, Kowalska A, Bereta G, Nowakowska Z, Plakwicz P, et al. Fibroblasts from recurrent fibrotic overgrowths reveal high rate of proliferation in vitro—findings from the study of hereditary and idiopathic gingival fibromatosis. Connective Tissue Research. 2019; 60: 29–39.

[43] Innes NPT, Ricketts D, Chong LY, Keightley AJ, Lamont T, Santamaria RM. Preformed crowns for decayed primary molar teeth. Cochrane Database of Systematic Reviews. 2015; 2015: CD005512.

[44] American Academy of Pediatric Dentistry. American Academy of Pediatric Dentistry reference manual 2011–2012. Pediatric Dentistry. 2011; 33: 1–349.

[45] Kindelan SA, Day P, Nichol R, Willmott N, Fayle SA; British Society of Paediatric Dentistry. UK national clinical guidelines in paediatric dentistry: stainless steel preformed crowns for primary molars. International Journal of Paediatric Dentistry. 2008; 18: 20–28.